Furthermore, patients with ACC have 2–53 times greater expression of TOP2A, IGF2, CDK1, CDK4, PLK4, and PLK1 genes than normal controls, of which the overexpression of CDK4 causes tumorigenesis via p53/Rb1-pathway-related cell cycle alterations [161]. This evidence concerns the gene CDK4 and adrenal cortex carcinoma.